Healthcare - Biotechnology - NASDAQ - US
$ 3.43
-9.26 %
$ 152 M
Market Cap
-2.01
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
1225.37%
EBIT
Estimate
--66.29%
Net Income
Estimate
52.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Checkpoint Therapeutics, Inc.
CKPT has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CKPT
EBIT FORECAST
EBIT Forecast Chart CKPT
NET INCOME FORECAST
Net Income Chart CKPT